dc.creatorGianecini, Ricardo A
dc.creatorRomero, María Mercedes
dc.creatorOviedo, Claudia
dc.creatorVacchino, Martin
dc.creatorGalarza, Patricia G.
dc.date2020-12-04T09:07:16Z
dc.date2020-12-04T09:07:16Z
dc.date2017-06
dc.date.accessioned2023-08-29T20:07:31Z
dc.date.available2023-08-29T20:07:31Z
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1813
dc.identifier10.1097/OLQ.0000000000000603
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519697
dc.descriptionFil: Gianecini, Ricardo. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Romero, Maria de Las Mercedes. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Oviedo, Claudia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Vacchino, Martin. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Galarza, Patricia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionBackground: The emergence of Neisseria gonorrhoeae strains with decreased susceptibility to cephalosporins represents a major concern globally. The aim of this study was to examine the phenotypic and molecular characteristics of N. gonorrhoeae isolates with decreased susceptibility to ceftriaxone and cefixime in Argentina. Methods: A total of 1987 isolates were collected during 2009 and 2013. The susceptibility to penicillin G, tetracycline, ciprofloxacin, cefixime, ceftriaxone, and azithromycin was determined using the agar dilution method. The major extended-spectrum cephalosporin resistance determinants (penA, mtrR, and porB1b) were sequenced in 42 N. gonorrhoeae isolates that showed decreased susceptibility to ceftriaxone (minimum inhibitory concentration [MIC], 0.06-0.125 mg/L) and cefixime (MIC, 0.125-0.25 mg/L). Genotyping by N. gonorrhoeae multiantigen sequence typing (NG-MAST) was performed. Results: Between 2009 and 2013, there was a shift in the modal MICs for ceftriaxone. Among the 42 isolates exhibiting decreased susceptibility to ceftriaxone and cefixime, 95.2% were resistant to penicillin G, 95.2% to tetracycline, 97.6% to ciprofloxacin, and 33.3% to azithromycin. Thirty-five (83.3%) of the 42 isolates had a mosaic penA allele XXXIV, which has been previously associated with resistance to ceftriaxone and cefixime as well as treatment failures. The isolates that contained the mosaic penicillin-binding protein 2 (PBP2) XXXIV were associated with NG-MAST ST1407 or closely related genotypes. Conclusions: In Argentina, N. gonorrhoeae isolates with decreased susceptibility to cefixime and ceftriaxone have now emerged, mostly due to the introduction of the internationally spread multidrug-resistant NG-MAST ST1407.
dc.formatpdf 
dc.languageen
dc.publisherLippincott, Williams & Wilkins
dc.relation#PLACEHOLDER_PARENT_METADATA_VALUE#
dc.relationdatasets
dc.relationSexually transmitted diseases
dc.rightsopen
dc.sourceSexually Transmitted Diseases 2017; 44(6):351-355
dc.subjectAntibacterianos
dc.subjectArgentina
dc.subjectCefixima
dc.subjectCeftriaxona
dc.subjectResistencia a las Cefalosporinas
dc.subjectGonorrea
dc.subjectHumanos
dc.subjectPruebas de Sensibilidad Microbiana
dc.subjectTipificación Molecular
dc.subjectNeisseria gonorrhoeae
dc.subjectFilogenia
dc.subjectVigilancia de Guardia
dc.subjectAnálisis de Secuencia de ADN
dc.titleEmergence and spread of Neisseria gonorrhoeae isolates with decreased susceptibility to extended-spectrum Cephalosporins in Argentina, 2009 to 2013
dc.typeArtículo


Este ítem pertenece a la siguiente institución